Emily J Gallagher
Video Visit Available
Accepting New Patients
Mount Sinai Verified Doctors IconMount Sinai DoctorsTreats Adults

Emily J Gallagher, MD, PhD

Emily Jane Gallagher (Preferred Name)

Endocrine, Diabetes and Bone Diseases (Endocrinology)

Calender Icon
Book an Appointment
White Right Arrow

About Me

Dr. Emily J. Gallagher is an Associate Professor in the Division of Endocrinology, Diabetes and Bone Disease and Associate Program Director of the Internal Medicine Residency Program. She is also the Director of the Research Track for the Internal Medicine Residency Program.

Dr. Gallagher earned her MB BCh BAO (MD equivalent) with honors from University College Dublin, Ireland and her PhD in Physiology and Medical Physics from the Royal College of Surgeons of Ireland. She is Board Certified in Internal Medicine and Endocrinology and is a Member of the Royal College of Physicians of Ireland (MRCPI).  Dr. Gallagher trained in Internal Medicine and Endocrinology at the Mater Miseriordiae University Hospital, Dublin, and completed her postgraduate training in Internal Medicine and Endocrinology at Mount Sinai. She was Chief Fellow in Endocrinology, and was subsequently appointed Assistant Professor of Medicine  Endocrinology, Diabetes and Bone Diseases.

She has been Principle Investigator on an Endocrine Fellows Foundation, Fellows Development Research Grant, and a K08 Clinician-Scientist Career Development Award from the NIH / NCI to study the role of hyperlipidemia in breast cancer progression. Dr. Gallagher is co-investigator on a number of NIH-funded studies. She has received a Tisch Cancer Institute at Mount Sinai Junior Scientist Research Award, a Mount Sinai Department of Medicine Junior Faculty Translational Collaborative Research Pilot Award and the Harold and Golden Lamport Research Award.

Dr. Gallagher’s clinical practice is in the field of onco-endocrinology: the management of endocrine and metabolic complications of cancer and its treatments. These complications of oncology treatments include: type 1 and type 2 diabetes drug induced hyperglycemia; dyslipidemia; complications of targeted therapies, small molecule inhibitors and immune checkpoint inhibitors that affect the pancreas, thyroid, pituitary and adrenal glands.

ASSOCIATE PROFESSOR | Medicine, Endocrinology, Diabetes and Bone Disease
Hospital Affiliations
  • The Mount Sinai Hospital
Multi-Disciplinary Training Areas

Cancer Biology [CAB]